CVE-2022-45193: Bruhn-Newtech Cbrn-Analysis

High severity, CVSS 8.8. EPSS: 0.5% chance of exploitation in the next 30 days.

CBRN-Analysis before 22 has weak file permissions under Public Profile, leading to disclosure of file contents or privilege escalation.

Affected products

• Bruhn-Newtech Cbrn-Analysis: before 22 (fixed in 22)

Published 2022-11-12. Last modified 2026-06-17.